This Week's Healthcare Earnings: J&J, Elevance, Tenet
Earnings season for the second quarter of the year kicked off recently with results from heavy hitters like Johnson & Johnson and Novartis this past week.
FDA Talks Transparency. Drug Cos. Ask How Far It Will Go
The first batch of rejection letters published as part of the FDA’s new transparency effort didn’t shake up the pharmaceutical industry. But future releases could trigger litigation and influence drug-development strategies, depending on how far the agency is willing to go.
Decades After Autism Omnibus, CDC Back In Thimerosal Fight
An unusual legal proceeding two decades ago tested claims that childhood vaccines caused autism. The "omnibus" proceeding found no such link, cutting off the primary legal path for such claims. Today, a CDC advisory panel reconstituted by HHS Secretary Robert F. Kennedy Jr. is reopening the debate.
This Week's Healthcare Earnings: J&J, Elevance, Tenet
Earnings season for the second quarter of the year kicked off recently with results from heavy hitters like Johnson & Johnson and Novartis this past week.
FDA Talks Transparency. Drug Cos. Ask How Far It Will Go
The first batch of rejection letters published as part of the FDA’s new transparency effort didn’t shake up the pharmaceutical industry. But future releases could trigger litigation and influence drug-development strategies, depending on how far the agency is willing to go.
Decades After Autism Omnibus, CDC Back In Thimerosal Fight
An unusual legal proceeding two decades ago tested claims that childhood vaccines caused autism. The "omnibus" proceeding found no such link, cutting off the primary legal path for such claims. Today, a CDC advisory panel reconstituted by HHS Secretary Robert F. Kennedy Jr. is reopening the debate.
Expert Analysis
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforce... (more story)
The revival of the False Claims Act working group is an aggressive expansion of enforcement efforts by the Justice... (more story)
Though the U.S. Food and Drug Administration has abandoned its usual notice-and-comment process for implementing n... (more story)
Deals & Corporate Governance More
A New York federal judge has ruled that a California-based bioscience company can enforce an arbitration award rejecting a more than $15 million claim asserted by a Hong Kong biopharmaceutical firm, saying the... (more story)
Aetna Inc.'s lawsuit alleging 23 pharmaceutical companies fixed prices for generic drugs seems like an attempt to work around a pause in similar Pennsylvania litigation, a Connecticut state judge said Monday, ... (more story)
Law360 is pleased to announce the Rising Stars of 2025, our list of more than 150 attorneys under 40 whose legal accomplishments belie their age.
A medical supply procurement company on Friday sought to hasten the assignment of a new judge to its contract suit against a pharmaceutical middleman after the previous judge retired, acknowledging there are s... (more story)
A New York federal judge has declined to dismiss a majority of the U.S. Securities and Exchange Commission's claims against former executives of a now-defunct online pharmacy called Medly, finding the agency a... (more story)
Personalized healthcare solutions company Accolade Inc. was hit with an investor suit Thursday accusing it and its CEO of making false statements about its profitability to prop up share prices before announci... (more story)
Digital Health & Technology More
Google, Meta Platforms and Criteo largely cannot escape litigation alleging GoodRx improperly shared patients' protected health information with the tech companies, a California federal judge ruled Tuesday.
Investors in medical tech manufacturer Becton Dickinson are seeking final approval of their $9 million deal that will end derivative claims the company was damaged by its attempts to hide regulatory problems r... (more story)
Five named plaintiffs testified Tuesday in a 13 million-member class action alleging Meta and Flo Health illegally collected their private health information and used it for ad targeting, telling a California ... (more story)
Meta illegally took private health information from over 30 million women who used Flo Health's menstrual cycle app, a lawyer for the plaintiffs told a California jury Monday during opening statements in their... (more story)
Dinsmore & Shohl LLP and a legal nonprofit have urged a Georgia federal court to toss a malpractice lawsuit brought by now-shuttered LabMD, saying the defunct cancer diagnostic company has abandoned the case w... (more story)
Stanford University was let out of all but one claim brought by subsidiaries of F. Hoffmann-La Roche AG over alleged trade secret theft, but a California federal judge allowed most claims to move forward again... (more story)
Policy & Compliance More
Reeling from a record fraud verdict tied to drug promotion practices, Johnson & Johnson is pursuing a sweeping constitutional challenge to the False Claims Act, and in filings this week at the Third Circuit, m... (more story)
A First Circuit panel refused to hit pause on a Massachusetts federal judge's order voiding cuts by the National Institutes of Health to hundreds of grant programs. Meanwhile, in California, a jury trial kicke... (more story)
A Connecticut federal judge has given dozens of state attorneys general a small but important win in a sprawling price-fixing litigation against generic-drug makers, applying previous admissions of criminal wr... (more story)
The Ohio Supreme Court on Tuesday agreed to review an appeals court's finding that portions of a state law restricting gender-affirming care for transgender youths are unconstitutional.
A federal judge slapped a temporary hold on parts of an Iowa law that aims to limit pharmacy benefit managers' power to set drug prices, ruling that provisions barring discrimination against certain pharmacies... (more story)
A North Carolina lab owner lost his bid Tuesday to overturn his healthcare fraud conviction after the Fourth Circuit found evidence against him to be sufficient and the terms of his sentence reasonable.